India Advances Gene Therapy with New Regulatory Guidelines

India is ramping up its efforts in gene therapy through enhanced regulatory frameworks aimed at ensuring safety, ethics, and compliance. Important government bodies, including the Central Drugs Standard Control Organisation (CDSCO), Indian Council of Medical Research (ICMR), and the Department of Biotechnology (DBT), have introduced the “National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019”. These guidelines provide critical direction for stakeholders involved in the research and development of gene therapeutic products.

The Department is progressively advancing India’s precision medicine landscape, emphasizing next-generation therapies that modify genetic materials through processes such as gene editing and augmentation. A significant milestone has been achieved with the first-in-human Phase-I clinical trial for gene therapy aimed at treating Hemophilia A, which showed promising results. The trial demonstrated stable production of Factor VIII, indicating a potential long-term solution to reduce bleeding episodes, and is documented in the esteemed New England Journal of Medicine.

BioE3 Policy and Support for Biotech Startups

The Union Cabinet recently approved the BioE3 (Biotechnology for Economy, Environment, and Employment) Policy, set to position India as a global biomanufacturing leader. The DBT is implementing this policy, which targets high-performance biomanufacturing across various sectors including agriculture, therapeutics, and chemicals.

This initiative aims to empower biotechnology startups and micro, small, and medium enterprises (MSMEs) by enhancing research and development support and facilitating partnerships between public and private entities. Noteworthy academic projects under this policy encompass the development of therapies for hematological diseases like Hemophilia, as well as innovative CAR-T Cell therapies.

Investment in Gene Therapy Research

Additionally, the DBT is sponsoring research initiatives at the Tata Institute for Genetics and Society in Bangalore. This project aims to create an indigenous mRNA-based gene-editing platform addressing propionic academia, a rare metabolic disorder. The BioE3 policy’s मूलांकुर BioEnablers scheme is another critical initiative, fostering biomanufacturing hubs equipped for large-scale production of clinical-grade cell and gene therapies.

Collaborative Efforts for Therapy Development

The Biotechnology Industry Research Assistance Council (BIRAC), a public sector organization under the DBT, is actively aiding startups in biodegradable technologies through funding, mentoring, and incubation. Programs like the Biotechnology Ignition Grant and the Sustainable Entrepreneurship and Enterprise Development Fund are designed to enhance technology development and commercialization within the biotech sector.

Moreover, ICMR is promoting several research projects targeting affordable gene therapy solutions through various funding initiatives. Their efforts include support for innovative projects and grant schemes aimed at increasing accessibility to gene therapies.

Regulatory Oversight and Safe Development

The regulatory landscape for gene therapies, including CRISPR technologies, is robust in India, governed by various guidelines that ensure their ethical development. The biosafety framework, stemming from the Environment (Protection) Act, mandates strict laboratory conditions for developing CRISPR therapies, overseen by Institutional Biosafety Committees and the Review Committee on Genetic Manipulation.

As these advancements unfold, the journey from clinical trials to market involves rigorous regulatory assessments by bodies such as CDSCO, ensuring that gene therapies meet stringent safety and quality standards. After successful trials, comprehensive documentation is submitted to CDSCO for marketing approval.

Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.

Follow Us on Twitter, Instagram, Facebook, & LinkedIn